Rothschild Investment LLC’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.17M Sell
50,015
-3,145
-6% -$281K 0.19% 107
2026
Q1
$3.82M Sell
53,160
-719
-1% -$55.4K 0.2% 106
2025
Q4
$4.28M Sell
53,879
-4,658
-8% -$367K 0.24% 94
2025
Q3
$4.41M Buy
58,537
+2,278
+4% +$156K 0.25% 90
2025
Q2
$3.88M Sell
56,259
-2,935
-5% -$192K 0.24% 99
2025
Q1
$4.01M Sell
59,194
-15,617
-21% -$935K 0.27% 88
2024
Q4
$3.36M Sell
74,811
-2,282
-3% -$128K 0.22% 104
2024
Q3
$4.85M Sell
77,093
-2,014
-3% -$117K 0.32% 77
2024
Q2
$4.67M Sell
79,107
-29,812
-27% -$1.86M 0.33% 73
2024
Q1
$8.69M Sell
108,919
-1,384
-1% -$106K 0.63% 41
2023
Q4
$8.71M Sell
110,303
-3,322
-3% -$236K 0.73% 33
2023
Q3
$7.93M Sell
113,625
-439
-0.4% -$31.1K 0.67% 39
2023
Q2
$7.88M Buy
114,064
+3,984
+4% +$283K 0.66% 39
2023
Q1
$8.18M Sell
110,080
-813
-0.7% -$68.2K 0.72% 37
2022
Q4
$10.3M Sell
110,893
-4,136
-4% -$399K 0.95% 26
2022
Q3
$11M Sell
115,029
-8,150
-7% -$807K 1.09% 18
2022
Q2
$11.4M Buy
123,179
+2,881
+2% +$281K 1.05% 19
2022
Q1
$12.2M Buy
120,298
+2,854
+2% +$300K 0.96% 24
2021
Q4
$12.1M Sell
117,444
-3,385
-3% -$313K 0.94% 27
2021
Q3
$10.3M Buy
120,829
+2,722
+2% +$228K 0.86% 28
2021
Q2
$9.86M Buy
118,107
+3,180
+3% +$260K 0.78% 34
2021
Q1
$8.65M Buy
114,927
+2,575
+2% +$188K 0.75% 35
2020
Q4
$7.67M Sell
112,352
-1,317
-1% -$85.7K 0.74% 35
2020
Q3
$6.64M Buy
113,669
+11,464
+11% +$713K 0.72% 42
2020
Q2
$6.64M Sell
102,205
-31,269
-23% -$1.97M 0.8% 34
2020
Q1
$7.92M Buy
133,474
+8
+0% +$534 1.03% 21
2019
Q4
$9.91M Buy
133,466
+34,870
+35% +$2.45M 0.99% 22
2019
Q3
$6.22M Sell
98,596
-123,534
-56% -$7.32M 0.73% 41
2019
Q2
$12.1M Sell
222,130
-4,448
-2% -$240K 1.43% 13
2019
Q1
$12.2M Buy
226,578
+56,467
+33% +$3.49M 1.43% 15
2018
Q4
$11.1M Buy
170,111
+23,919
+16% +$1.79M 1.49% 14
2018
Q3
$11.5M Buy
146,192
+3,077
+2% +$220K 1.36% 15
2018
Q2
$9.21M Buy
143,115
+8,913
+7% +$587K 1.16% 19
2018
Q1
$8.35M Sell
134,202
-9,113
-6% -$654K 1.07% 28
2017
Q4
$10.4M Buy
143,315
+89,307
+165% +$6.49M 1.13% 22
2017
Q3
$4.39M Buy
54,008
+10,730
+25% +$849K 0.5% 54
2017
Q2
$3.48M Buy
43,278
+2,924
+7% +$231K 0.4% 61
2017
Q1
$3.17M Buy
40,354
+12,773
+46% +$1.02M 0.37% 67
2016
Q4
$2.18M Buy
27,581
+386
+1% +$31.2K 0.26% 100
2016
Q3
$2.42M Buy
27,195
+5,767
+27% +$544K 0.3% 93
2016
Q2
$2.05M Sell
21,428
-25,250
-54% -$2.52M 0.26% 101
2016
Q1
$4.84M Buy
46,678
+2,248
+5% +$219K 0.62% 43
2015
Q4
$4.34M Sell
44,430
-115
-0.3% -$11.3K 0.55% 50
2015
Q3
$4.3M Sell
44,545
-450
-1% -$47.3K 0.57% 48
2015
Q2
$4.72M Sell
44,995
-876
-2% -$89.5K 0.55% 46
2015
Q1
$4.73M Sell
45,871
-868
-2% -$87.8K 0.55% 47
2014
Q4
$4.5M Buy
46,739
+18,311
+64% +$1.61M 0.54% 46
2014
Q3
$2.26M Sell
28,428
-1,416
-5% -$112K 0.28% 87
2014
Q2
$2.25M Sell
29,844
-25,752
-46% -$1.95M 0.29% 87
2014
Q1
$4.16M Buy
55,596
+20,808
+60% +$1.47M 0.56% 51
2013
Q4
$2.49M Sell
34,788
-400
-1% -$25.7K 0.34% 74
2013
Q3
$2M Sell
35,188
-930
-3% -$55.4K 0.29% 82
2013
Q2
$2.06M Buy
+36,118
New +$2.09M 0.34% 74

Other funds holding CVS

Rothschild Investment LLC's CVS Position: Q2 2026 in Review

Rothschild Investment LLC reduced its CVS Health (CVS) stake by 5.9% in Q2 2026, selling an estimated $281K and leaving 50,015 shares worth $5.17M. The position accounts for 0.19% of the portfolio, ranked #107.

Rothschild Investment LLC first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.2M in Q1 2019. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Rothschild Investment LLC held 50,015 shares of CVS Health worth $5.17M as of Q2 2026.
  • Rothschild Investment LLC sold 3,145 CVS Health shares in Q2 2026, an estimated $281K.
  • CVS Health made up 0.19% of Rothschild Investment LLC's portfolio in Q2 2026, its #107 holding.
  • Rothschild Investment LLC first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Rothschild Investment LLC's CVS Health position peaked at $12.2M in Q1 2019.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.